Erythropoietin and GM-CSF following autologous bone marrow transplantation.
Centro Transfusionale CRS, Locarno, Switzerland.
A
A
Pedrazzini
D016026:Bone Marrow Transplantation; D004359:Drug Therapy, Combination; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006098:Granulocytes / Q000473:pathology; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D008533:Megakaryocytes / Q000473:pathology; D009369:Neoplasms / Q000097:blood* / Q000628:therapy; D010865:Pilot Projects; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor